Department of Medicine
Pankti Reid specializes in rheumatology with specific interest in pharmacogenomics (how patients’ genetics affect their response to medications) and its impact on patient care within rheumatology. Her clinic cares for patients with an array of rheumatic conditions and autoimmune diseases. In particular, she is developing a clinic to evaluate and manage patients who suffer from adverse events secondary to cancer immunotherapy agents. Checkpoint inhibitors are types of cancer immunotherapy agents that harness patients’ own immune systems to combat their cancers. However, the use of these agents can sometimes lead to side effects called immune-related adverse events (irAEs) that are akin to autoimmune diseases. Reid is working to better diagnose and treat patients with irAEs.
Her research has been published in the Journal of Immunotherapy, Arthritis and Rheumatology, and American Journal of Kidney Diseases. She is the recipient of the Arnold P. Gold Foundation Humanism and Excellence in Teaching Award and has received support from the Institution for Translational Medicine at the University of Chicago.
Reid received her MD from The Ohio State University School of Medicine and an MPH from Tulane University. She completed her residency in internal medicine at the University of Cincinnati, followed by a rheumatology fellowship at the University of Chicago and a fellowship through the University of Chicago’s Committee on Clinical Pharmacology and Pharmacogenomics.